Incorrect blister count during distribution prep – recall risk analysis


Published on 14/01/2026

Managing Risks Associated with Incorrect Blister Count during Distribution Preparation

The pharmaceutical industry is no stranger to challenges in manufacturing and quality control, particularly concerning machine operation. One recurrent issue that poses significant risks is an incorrect blister count during the distribution preparation phase. Such discrepancies not only threaten product integrity but can also lead to severe regulatory implications, including recalls. In this article, we will explore how to effectively identify, contain, and resolve this issue while ensuring compliance with GMP requirements.

To understand the bigger picture and long-term care, read this Blister & Cartoning Machine Issues.

By the end of this guide, you will be equipped with actionable steps to address incorrect blister counts efficiently through a structured workflow, ultimately minimizing the risk of recalls and preparing your facility for rigorous FDA or EMA inspections.

Symptoms/Signals on the Floor or in the Lab

Recognizing the symptoms of

an incorrect blister count is critical for timely intervention. Below are common indicators that can pinpoint the issue:

  • Inconsistency in Blister Count: Manual counts diverging from machine counts during line checks.
  • Customer Complaints: Reports of incorrect blister counts from distribution partners.
  • Quality Control Findings: Deviations reported during quality assurance checks post-production.
  • Machine Alarms: Alarms triggered by count verification systems on blister and cartoning machines.
  • Observation of Physical Products: Pallets arriving at distribution centers having packaging that does not match batch records.

Any of these signals necessitate immediate evaluation and action to prevent potential risks associated with product recall or regulatory breaches.

Likely Causes

To tackle the problem effectively, it is crucial to categorize and analyze the potential causes of incorrect blister counts. Root causes can generally be broken down into the following categories:

Category Likely Causes
Materials Defective or incorrect blister material size leading to miscounts.
Method Inadequate SOPs for handling blister production that does not align with machine protocols.
Machine Malfunctioning sensors or software glitches in the blister or cartoning machine.
Man Human errors during packaging operations or audits resulting in count discrepancies.
Measurement Inaccurate calibration of counting mechanisms within the machines.
Environment Unstable manufacturing environment influencing machine performance (e.g., humidity affecting material properties).
Pharma Tip:  Vision system rejection after artwork change – CAPA breakdown

Understanding these categories helps refine the focus of the investigation efforts to isolate root causes more effectively.

Immediate Containment Actions (First 60 Minutes)

Time is of the essence when a discrepancy is detected. Here are immediate containment actions to take within the first hour:

  1. Halt Production: Immediately stop the production line where the incorrect blister count was identified.
  2. Implement a Quarantine: Isolate all affected products in a controlled area to prevent distribution.
  3. Document Observations: Record all relevant observations, including batch numbers, machine settings, and the time of occurrence.
  4. Notify Key Personnel: Involve Management, QC, and Engineering teams in the initial notification phase.
  5. Initiate a Preliminary Investigation: Start gathering evidence, such as process parameters and machine logs to assess the situation.

Maintaining documentation during this stage is crucial as it forms the basis for the forthcoming investigation and auditing processes.

Investigation Workflow (Data to Collect + How to Interpret)

Conducting a thorough investigation is essential for understanding the scope and origin of the failure. The following steps outline the data collection framework:

  • Initial Data Logging: Capture the production schedule, machine logs, and personnel involved.
  • Count Verification: Recheck the count of produced blisters against the records immediately along with random samples.
  • Calibration Records Review: Assess the calibration history of the blister counting mechanisms prior to production.
  • Audit SOPs: Ensure that current operating procedures are being adhered to and reflect correct practices.
  • Environmental Conditions: Evaluate the conditions at the time of operation, including temperature and humidity data.

The collected data will lead to identifying patterns or recurrent issues that may serve as indicators of systemic problems, rather than isolated incidents.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

Addressing an incorrect blister count requires systematic analysis using established root cause analysis tools.

  • 5-Why Analysis: Best used for straightforward, clear issues. This method involves asking “why?” multiple times (usually five) to reach the root cause. It’s powerful for uncovering the underlying reasoning behind a specific count error.
  • Fishbone Diagram: Ideal for complex issues with multiple potential causes. It helps visualize all categories of potential failures affecting blister counts and compiles them to assess correlations.
  • Fault Tree Analysis: Suitable for critical failures where consequences are significant. This method decomposes the problem to a diagrammatic representation, showing cause-and-effect relationships and aiding in hypothesis testing.

Choosing the right tool depends on the complexity of the problem, the potential impact of the failure, and the desired level of detail in the analysis.

Pharma Tip:  Foil tearing issue during inspection – recall risk analysis

CAPA Strategy (Correction, Corrective Action, Preventive Action)

Once the root cause is identified, a comprehensive CAPA strategy must be developed:

  • Correction: Immediate rectification of the counted blisters through re-inspection or adjustment of machine settings.
  • Corrective Action: Implement measures to resolve the root cause, such as retraining staff, recalibrating machines, or revising SOPs that contributed to the failure.
  • Preventive Action: Introduce preventative strategies to guard against future occurrences. This could include enhanced monitoring systems or routine audits of machine performance and SOP compliance.

All CAPA actions should be documented meticulously to ensure a compliant audit trail for both internal assessments and regulatory inspections.

Control Strategy & Monitoring (SPC/Trending, Sampling, Alarms, Verification)

An effective control strategy ensures that the risk of incorrect blister counts is constantly monitored throughout production. Here are the key components:

Related Reads

  • Statistical Process Control (SPC): Utilize SPC techniques to monitor control processes and identify variations in blister counts.
  • Routine Sampling: Schedule regular sampling of blister counts for verification against production logs.
  • Alarm Systems: Integrate automated alarm systems to alert operators of deviations from the acceptable blister count range.
  • Verification Processes: Establish verification processes post-production to ensure blister counts match packaging records accurately.

Implementing these control strategies enhances overall production reliability and minimizes risk, while also improving readiness for regulatory inspections.

Validation / Re-qualification / Change Control Impact (When Needed)

Changes resulting from the investigations, whether in equipment or processes, warrant revisiting validation and re-qualification practices:

  • Validation Practices: Review and update validation documentation to reflect any modifications made in machine settings or processes.
  • Re-qualification: Ensure re-qualification of any equipment impacted by the corrections to guarantee they meet regulatory standards prior to use.
  • Change Control Procedures: Follow established change control procedures to manage any adjustments in protocols or equipment configurations.

Assessing these changes through appropriate validation channels ensures ongoing compliance with industry standards and prepares the facility for audits.

Inspection Readiness: What Evidence to Show

Being inspection-ready requires robust documentation that demonstrates adherence to GMP standards:

  • Records of Investigation: Maintain all records associated with the investigation, including the collected data, root cause analysis, and CAPA documentation.
  • Training Records: Document training programs undertaken by personnel regarding improvements in procedures or practices related to blister production.
  • Machine Logs: Keep thorough machine logs reflecting performance, maintenance, calibration, and changes made post-investigation.
  • Deviation Reports: Archive deviation reports and the associated actions taken, along with how they tie back to the original issue.
  • Review Protocols: Regular audits of these documents should be conducted to ensure availability and compliance during inspections.
Pharma Tip:  Incorrect blister count during cartoning – CAPA breakdown

Presenting clear and organized records at inspection time can mitigate potential issues and demonstrate a proactive approach to quality management.

FAQs

What should I do if I find an incorrect blister count?

Immediately halt production, quarantine affected products, and begin an investigation as outlined in this guide.

How can I prevent future blister count discrepancies?

Implement a robust monitoring system, complete regular training for personnel, and maintain updated SOPs reflective of current best practices.

What is the timeline for a corrective action plan?

The timeline varies depending on the complexity of the root cause; however, corrective actions should be initiated as soon as possible after the incident is identified.

Is it necessary to document every CAPA decision?

Yes, all decisions related to CAPAs must be documented to fulfill regulatory requirements and maintain a clear audit trail.

What role do audits play in preventing incorrect blister counts?

Regular audits help identify potential issues in processes and documentation, ensuring that SOP adherence is evaluated and enforced.

Can equipment failures contribute to incorrect blister counts?

Absolutely. Malfunctioning equipment, sensors, or software can lead directly to errors in blister counting.

Do I need to retrain staff after a quality issue?

Yes, retraining is often necessary to reinforce correct practices and ensure that all team members are aware of the new procedures following a quality issue.

How often should I perform calibration of blister counting machines?

Calibration frequency should be based on the manufacturer’s specifications and any historical data showing trends of deviation.

What records are critical for FDA/EMA inspections?

Key records include investigation results, CAPA documentation, training records, machine logs, and deviation reports.

Is there a specific regulatory guideline for blister packaging counts?

While specific guidelines may vary by region, adherence to GMP regulations as defined by the FDA, EMA, or MHRA is critical for all pharmaceutical manufacturing.

What should be included in an inspection readiness checklist?

An inspection readiness checklist should include key records, audit results, training compliance, and updated SOPs, among other essential documentation.